Dr Peter Carey (Regional Lipid Advisor) discusses key product information, eligible patient groups, and how LEQVIO® is used in the lipid management pathway.
Watch Dr Matt Kearney (Director at UCLPartners AHSN) consider why cholesterol and cardiovascular disease management is a key focus for NHS England right now.
Professor Kelvin Lee discusses how you can identify patients eligible for LEQVIO® in both the inpatient and outpatient setting using three illustrative patient scenarios.
Join Professor Azfar Zaman in this webinar who discusses how LEQVIO® can be used to help reduce cholesterol. Professor Zaman highlights the recommendations from NICE
Professor Kelvin Lee discusses how to identify eligible LEQVIO® patients in the inpatient and outpatient setting and how this has been achieved in Lincolnshire.
Professor Azfar Zaman presents the efficacy and safety data from three LEQVIO® clinical trials as well as discussing NICE recommendations.
-
See more results
277 remaining items
Welcome to Pro.Novartis.com
The Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers* is where you can find promotional information about Novartis products, therapy area materials and professional resources.
*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.
Welcome to Pro.Novartis.com
The Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers* is where you can find promotional information about Novartis products, therapy area materials and professional resources.
*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.